PolymarketComprobar disponibilidadSin KYCDatos de resolución verificadosBien calibradoPunto medio del libro seleccionado
No · —
Cargando el libro seleccionado…
—
Referencia guardada
No 97%
No 97%Calidad del mercado
≤49 / 100
Baja calidadVolumen 24h
—
Liquidez
73,4 mil €
Alta liquidezInterés abierto
16,1 mil US$
Compra / Venta
— / —
NoSpread
—
Comentarios
7
Cambio 7d
-0.1 pts
Datos de mercado
Actualizado hace 17 minutos
4 may 26, 14:41 UTC1 ene 27, 4:59 UTC
El gráfico y los cambios muestran probabilidades históricas guardadas, no el libro seleccionado en directo.
Tendencias
Fila seleccionada: punto medio del libro. Otras filas: referencias guardadas, posiblemente normalizadas; los cambios de 24h usan el historial guardado.
Condiciones de la plataforma
Fuente: Polymarket
Estas condiciones son informativas; las operaciones simuladas de CoinRithm siguen sus propias reglas.
- Orden mínima (participaciones):
- 5
- Incremento de precio:
- 0,1 puntos porcentuales
- Comisiones:
- Sí
Principales tenedores
Cargando principales tenedores
Profundidad de mercado · No
Cargando el libro seleccionado…
—
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will a Hantavirus Vaccine be created in 2026? [Polymarket]
Manifold MarketsHow many human screwworm cases will be reported in the United States in 2026?
KalshiWhen will Beam Therapeutics submit a BLA for Risto-cel?
KalshiHow many tuberculosis cases will be reported in the United States in 2026?
KalshiWhat will the phase 3 clinical trial results report for vaccine efficacy (%) of the R21 malaria vaccine at 24 months?
Manifold MarketsWill WHO classify the current hantavirus outbreak as a Public Health Emergency of International Concern by end of 2026?
Manifold MarketsReglas
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.